Other grades of this product :
| C16 PEG2 CERAMIDE Basic information |
| Product Name: | C16 PEG2 CERAMIDE | | Synonyms: | C16 PEG2 CERAMIDE;N-PALMITOYL-SPHINGOSINE-1-[SUCCINYL(METHOXY POLYETHYLENE GLYCOL) 2000];C16 PEG(2000) Ceramide;C16 PEG(5000) Ceramide;N-PALMITOYL-SPHINGOSINE-1-{SUCCINYL[METHOXY(POLYETHYLENE GLYCOL)750]};C16 PEG750 CERAMIDE;N-PALMITOYL-SPHINGOSINE-1-{SUCCINYL[METHOXY(POLYETHYLENE GLYCOL)2000]};C16 PEG2000 CERAMIDE;N-PALMITOYL-SPHINGOSINE-1-{SUCCINYL[METHOXY(POLYETHYLENE GLYCOL)5000]};C16 PEG5000 CERAMIDE;C16 PEG Ceramide, MW 750 | | CAS: | 212116-78-4 | | MF: | | MW: | 0 | | EINECS: | | Product Categories: | | Mol File: | Mol File |
| C16 PEG2 CERAMIDE Chemical Properties |
| C16 PEG2 CERAMIDE Usage And Synthesis |
| Description | C16 PEG Ceramide, MW 750 is used for liposome preparation with NMR studies and PEGylated lipoplexes preparation. | | Uses | C16 PEG750 Ceramide might be used as a control to test for nonspecific interactions during titrations of DNA-nanotube complexes with polyethylene glycol (PEG)-conjugated lipids. | | Uses | C16 PEG5000 Ceramide might be used to stabilize nanosized bilayer disks and in the preparation of lipid aggregates. | | General Description | Ceramide is a sphingolipid metabolite. The ceramides differ in their acyl chain length. | | Biochem/physiol Actions | Therapeutic drugs enclosed in poly-ethylene glycol (PEG) conjugated ceramide serves as liposomal carriers, ensuring a longer circulation period. It exhibits a neutral surface electrostatic charge which prevents the leakage of positively charged encapsulated drug molecule. |
| C16 PEG2 CERAMIDE Preparation Products And Raw materials |
|